Correlation Between IShares Biotechnology and IShares Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Biotechnology and IShares Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Biotechnology and IShares Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Biotechnology ETF and iShares Healthcare ETF, you can compare the effects of market volatilities on IShares Biotechnology and IShares Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Biotechnology with a short position of IShares Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Biotechnology and IShares Healthcare.

Diversification Opportunities for IShares Biotechnology and IShares Healthcare

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between IShares and IShares is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding iShares Biotechnology ETF and iShares Healthcare ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Healthcare ETF and IShares Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Biotechnology ETF are associated (or correlated) with IShares Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Healthcare ETF has no effect on the direction of IShares Biotechnology i.e., IShares Biotechnology and IShares Healthcare go up and down completely randomly.

Pair Corralation between IShares Biotechnology and IShares Healthcare

Considering the 90-day investment horizon IShares Biotechnology is expected to generate 4.19 times less return on investment than IShares Healthcare. In addition to that, IShares Biotechnology is 1.52 times more volatile than iShares Healthcare ETF. It trades about 0.0 of its total potential returns per unit of risk. iShares Healthcare ETF is currently generating about 0.02 per unit of volatility. If you would invest  5,688  in iShares Healthcare ETF on August 23, 2024 and sell it today you would earn a total of  377.00  from holding iShares Healthcare ETF or generate 6.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

iShares Biotechnology ETF  vs.  iShares Healthcare ETF

 Performance 
       Timeline  
iShares Biotechnology ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Biotechnology ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Etf's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.
iShares Healthcare ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Healthcare ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.

IShares Biotechnology and IShares Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Biotechnology and IShares Healthcare

The main advantage of trading using opposite IShares Biotechnology and IShares Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Biotechnology position performs unexpectedly, IShares Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Healthcare will offset losses from the drop in IShares Healthcare's long position.
The idea behind iShares Biotechnology ETF and iShares Healthcare ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk